“At Cycle, we are committed to setting new standards in the pharmaceutical industry. Working together around the world to provide patients with rare diseases access to high quality and safe medicines”

CLAUDIA PERCIVALLE, Head of Global Regulatory Affairs

Continuous monitoring of the safety of a drug throughout the duration of its use helps to ensure that its risks and benefits remain acceptable. Cycle is committed to protecting the safety of patients who receive our products.

If you have experienced an adverse event or think you may be experiencing an adverse event, you should seek advice from a healthcare professional.

An adverse event is the development of an undesirable medical condition or the deterioration of a pre-existing medical condition following or during exposure to a pharmaceutical product, whether or not considered causally related to the product. An undesirable medical condition can be symptoms (e.g. nausea, chest pain), signs (e.g. tachycardia, enlarged liver) or the abnormal results of an investigation (e.g., laboratory findings, electrocardiogram).

All adverse events should be reported to Cycle Pharmaceuticals by calling (toll-free USA and Canada) +1-855-831-5413; or by email at cycle@pharmacovigilance.center